Jake Simson

Insider Reports History

Entity
Individual
Location
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature
/s/ Ran Xiao, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jake Simson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 2.5K $137K $54.75 Jun 26, 2024 Direct
Bicara Therapeutics Inc. Director Stock Option (Right to Buy) 23.7K Sep 12, 2024 Direct
Tyra Biosciences, Inc. Director Stock Option (Right to Buy) 18.6K May 29, 2024 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 8.35K Jun 26, 2024 Direct
DICE Therapeutics, Inc. Director Stock Option (right to buy Common Stock) 0 Aug 9, 2023 Direct

Insider Reports Filed by Jake Simson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 Director
BCAX Bicara Therapeutics Inc. Sep 12, 2024 1 $0 4 Sep 16, 2024 Director
BCAX Bicara Therapeutics Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director
JANX Janux Therapeutics, Inc. Jun 26, 2024 2 $0 4 Jun 28, 2024 Director
TYRA Tyra Biosciences, Inc. May 29, 2024 1 $0 4 May 31, 2024 Director
DICE DICE Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 Director
JANX Janux Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
TYRA Tyra Biosciences, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
JANX Janux Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
TYRA Tyra Biosciences, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
DICE DICE Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
TYRA Tyra Biosciences, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Director
DICE DICE Therapeutics, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Director
JANX Janux Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Director